Loading…
Loading…
ICHR does not currently pay a dividend.
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
Click below to see what's inside, then upgrade to unlock for ICHR and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for ICHR and 80,000+ other tickers.
See exactly how ICHR's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for ICHR and 80,000+ other tickers.
Ichor Holdings, Ltd. specializes in the conception, development, and production of fluid delivery subsystems and their constituent components, tailored for capital equipment used in semiconductor manufacturing. The company's primary focus is on gas and chemical handling systems, which are integral to the fabrication of semiconductor devices. Their gas delivery units are engineered to precisely supply, monitor, and regulate gases for critical processes like etching and deposition. Complementarily, their chemical delivery subsystems accurately blend and dispense reactive liquid chemistries…
The transaction involved 10,587 shares with an estimated value of ~$550,000 based on the September 1, 2026 weighted average execution price. The trade size was ~10% of the officer's direct equity holdings prior to the filing.
Ichor Holdings (ICHR) reported earnings 30 days ago. What's next for the stock?
Ichor Holdings is benefiting from a semiconductor equipment demand recovery, driving strong revenue and margin growth. Q2 2026 revenue rose 24% YoY to $294.8M, with non-GAAP EPS reaching $0.34 and non-GAAP gross margin improving to 14.1%. Management guides for further sequential growth in Q3, forecasting $315–345M revenue and $0.40–0.50 non-GAAP EPS.
Ichor Holdings offers a compelling risk/reward profile after a sharp valuation reset, trading at $57 despite strong operational momentum. ICHR's margin expansion is structurally driven by proprietary content, internalization, and manufacturing footprint shifts, with sequential 100bps gains and a path to 20% gross margin. Management guides for 30%+ revenue growth in 2026 and is preparing for $2–3bn annual capacity, supported by a net cash balance sheet and disciplined opex.
I reiterate Ichor Holdings (ICHR) as a Strong Buy with a revised price target of $82. Q2 2026 results demonstrated 15% sequential and 23% y/y revenue growth, with non-GAAP EPS reaching a three-year high and gross margin beating guidance. Management guides for a steep H2 2026 revenue ramp, projecting at least 30% full-year revenue growth and 25% higher H2 vs. H1 revenues.